WallStSmart

CME Group Inc (CME)vsDatacentrex, Inc. (DTCX)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 84160% more annual revenue ($6.96B vs $8.26M). CME leads profitability with a 63.5% profit margin vs -234.5%. CME earns a higher WallStSmart Score of 63/100 (C+).

CME

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 8.0Value: 4.3Quality: 4.5
Piotroski: 1/9Altman Z: -0.67

DTCX

Avoid

24

out of 100

Grade: F

Growth: 3.7Profit: 2.5Value: 5.0Quality: 7.8
Piotroski: 5/9Altman Z: 67.13

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME5 strengths · Avg: 9.2/10
Profit MarginProfitability
63.5%10/10

Keeps 64 of every $100 in revenue as profit

Operating MarginProfitability
66.2%10/10

Strong operational efficiency at 66.2%

Market CapQuality
$112.93B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

Free Cash FlowQuality
$1.07B8/10

Generating 1.1B in free cash flow

DTCX2 strengths · Avg: 10.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
67.1310/10

Safe zone — low bankruptcy risk

Areas to Watch

CME4 concerns · Avg: 2.8/10
P/E RatioValuation
25.9x4/10

Moderate valuation

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
4.362/10

Expensive relative to growth rate

Altman Z-ScoreHealth
-0.672/10

Distress zone — elevated risk

DTCX4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$46.61M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-15.8%2/10

ROE of -15.8% — below average capital efficiency

Revenue GrowthGrowth
-29.1%2/10

Revenue declined 29.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.5% and operating margin at 66.2%. Revenue growth of 13.0% demonstrates continued momentum.

Bull Case : DTCX

The strongest argument for DTCX centers on Price/Book, Altman Z-Score.

Bear Case : CME

The primary concerns for CME are P/E Ratio, Piotroski F-Score, PEG Ratio.

Bear Case : DTCX

The primary concerns for DTCX are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

CME profiles as a mature stock while DTCX is a turnaround play — different risk/reward profiles.

CME is growing revenue faster at 13.0% — sustainability is the question.

CME generates stronger free cash flow (1.1B), providing more financial flexibility.

Monitor FINANCIAL DATA & STOCK EXCHANGES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CME scores higher overall (63/100 vs 24/100), backed by strong 63.5% margins and 13.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

Datacentrex, Inc.

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

Datacentrex, Inc. is an industrial-scale blockchain infrastructure company that focuses on Dogecoin and Litecoin mining. The company is headquartered in Los Angeles, California.

Want to dig deeper into these stocks?